Det er ikke sandsynligt, at anidulafungin vil have klinisk betydende effekt på metabolismen af lægemidler, der metaboliseres via cytochrom P450- isoenzymer.
It is unlikely that anidulafungin will have clinically relevant effects on the metabolism of drugs metabolised by cytochrome P450 isoenzymes.